Insulin Dose Adjustments for Insulin-Resistant Type 2 Diabetes
This patient requires immediate and substantial increases in all insulin parameters: increase Lantus to 35-40 units daily, tighten the insulin-to-carbohydrate ratio to 1:4-5 grams, and reduce the insulin sensitivity factor to 15-20 mg/dL per unit.
Rationale for Dose Adjustments
Basal Insulin (Lantus) Increase
The current 24 units of Lantus is grossly inadequate. The blood glucose data reveals:
- Morning BG of 357 mg/dL indicates severe basal insulin deficiency
- Despite correction insulin at 11 PM, BG remained elevated at 211 mg/dL at 2 AM
- The patient weighs 37 kg, currently receiving only 0.65 units/kg
Increase Lantus from 24 to 35-40 units (approximately 1.0-1.1 units/kg). This aligns with the 2025 ADA guidelines recommending titration by 2-4 units every 3 days until fasting plasma glucose reaches target 1. Given the severe hyperglycemia (FPG 357 mg/dL), aggressive titration is warranted. Use the evidence-based algorithm: increase by 6-8 units when glucose ≥180 mg/dL 2.
Insulin-to-Carbohydrate Ratio (ICR) Adjustment
The current ICR of 1:6 is far too weak. The data demonstrates:
- At noon: ate 67g CHO, BG dropped from 357 to 124 (233 mg/dL drop with ~11 units)
- At 5 PM: ate 81g CHO, BG rose from 124 to 227 (103 mg/dL rise)
- At 6 PM to 10 PM: BG rose from 227 to 358 (131 mg/dL rise), indicating missed coverage
Tighten ICR to 1:4-5 grams per unit of insulin. Research shows that for insulin-resistant type 2 diabetes patients, the traditional 500 rule underestimates insulin needs 3. The study found CIR×TDD should be 300-400, not 500. With an estimated total daily dose of 60-70 units after adjustments, this yields an ICR of 1:4-5 grams.
Insulin Sensitivity Factor (ISF) Adjustment
The current ISF of 25 mg/dL per unit is inadequate:
- At 11 PM: BG 325 mg/dL, received 6 units correction
- At 2 AM: BG only dropped to 211 mg/dL (114 mg/dL drop with 6 units = 19 mg/dL per unit actual sensitivity)
Reduce ISF to 15-20 mg/dL per unit. This reflects the patient's demonstrated insulin resistance. The traditional 1800 rule (for regular insulin) or 1500 rule (for rapid-acting) significantly overestimates sensitivity in insulin-resistant patients.
Implementation Strategy
Immediate Actions:
- Increase Lantus by 12-16 units (to 36-40 units total), administered at the same time daily
- Change ICR to 1:4 for all meals initially (can adjust breakfast separately if needed, as breakfast often requires more insulin 3)
- Change ISF to 1:15 for correction doses
- Titrate Lantus every 3 days by 2-4 units until fasting BG consistently <130 mg/dL, then <100 mg/dL 1
Monitoring Requirements:
- Check fasting BG daily to guide basal titration
- Check pre-meal and 2-hour post-meal BG to assess ICR adequacy
- Document all carbohydrate intake accurately
- Watch for hypoglycemia, though unlikely given current insulin resistance
Critical Considerations
Basal-to-Total Daily Dose Ratio: Research in type 2 diabetes suggests optimal basal insulin comprises 35-46% of total daily dose 4. With the proposed adjustments (40 units basal + approximately 25-30 units prandial = 65-70 units total), the basal proportion would be 57-62%, which is acceptable in insulin-resistant type 2 diabetes where basal needs are often higher.
Address the Root Problem: This patient's high carbohydrate intake and frequent snacking are sabotaging glycemic control. While adjusting insulin doses addresses the immediate hyperglycemia, strongly recommend reducing total carbohydrate intake to 30-45 grams per meal and eliminating between-meal snacking. Consider adding a GLP-1 receptor agonist to reduce appetite and insulin resistance 1.
Hypoglycemia Risk: Given the current severe hyperglycemia and demonstrated insulin resistance, the risk of hypoglycemia with these increases is low. However, if the patient suddenly improves dietary habits or loses weight, doses will need rapid downward adjustment.
Weight Considerations: At 37 kg, this patient is significantly underweight for a 53-year-old adult. Investigate for malabsorption, hyperthyroidism, or other causes of low body weight that may be contributing to erratic glucose control.